Trial Profile
Clinical Trials Insight: 700052482
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 11 Jan 2010
Price :
$35
*
At a glance
- Drugs Selisistat (Primary)
- Indications Huntington's disease
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Elixir Pharmaceuticals
- 11 Jan 2010 New trial record.